Hostname: page-component-cd9895bd7-8ctnn Total loading time: 0 Render date: 2024-12-29T11:11:56.108Z Has data issue: false hasContentIssue false
  • English
  • Français

Neuroleptic Malignant Syndrome (NMS) and Tardive Dyskinesia

Published online by Cambridge University Press:  02 January 2018

Adityan Jee
Adityan Jee*
Affiliation:
Department of Psychological Medicine University of Malaya 59100 Kuala Lumpur Malaysia
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Correspondence
Information
The British Journal of Psychiatry , Volume 150 , Issue 6 , June 1987 , pp. 880
Copyright
Copyright © 1987 The Royal College of Psychiatrists 

References

Caroff, S. N. (1980) The neuroleptic malignant syndrome. Journal of Clinical Psychiatry, 41, 79–83.Google ScholarPubMed
Corlon, P. (1986) The spectrum concept of neuroleptic toxicity. American Journal of Psychiatry, 143, 811.Google Scholar
Shalev, A. & Munitz, H. (1986) The neuroleptic malignant syndrome: agent and host interaction. Acta Psychiatrica Scandinavica. 73, 337–347.CrossRefGoogle ScholarPubMed
Sternberg, D. E. (1986) Neuroleptic malignant syndrome: the pendulum swings. American Journal of Psychiatry, 143, 1273–1275.Google ScholarPubMed
Woo, J., Tech, R. & Vallence-Owen, J. (1986) Neuroleptic malignant syndrome successfully treated with amantidine. Postgraduate Medical Journal, 62, 809–810.CrossRefGoogle ScholarPubMed
Submit a response

eLetters

No eLetters have been published for this article.